Oncology Venture is represented at the 4th Biotech & Money World Congress in London, 5-6th February.
Hørsholm, Denmark, 5th of February 2018 – Oncology Venture Sweden AB (OV:ST) reports from the 4th Biotech & Money World Congres. Oncology Venture have scheduled meetings with several companies on the 5-6th February. These companies are potential investors or biotech/pharma with interest in either in-licensing or co-development of oncology drugs or companies with drugs of interest to Oncology Venture for in-licensing. Further, OV will give a presentation of the company on the 6th February. For further information, please contact: Ulla Hald Buhl, COO och chef för IR & kommunikation